Investing
Top 10 Analyst Upgrades, Downgrades, Initiations (ANF, AGAM, BIDU, DE, GENZ, HBC, SVA, USB, X, FCX)
Published:
Last Updated:
These are this morning’s top pre-market analyst upgrades, downgrades, and initiations seen in Wall Street research calls:
Abercrombie & Fitch (ANF) Raised to Outperform at FBR.
AGA Medical (AGAM) Started as Buy at Citigroup; Started as Market Perform at Wells Fargo; Started as Buy at Deutsche Bank.
Baidu, Inc. (BIDU) Cut to Market Perform at Bernstein.
Deere & Co. (DE) Raised to Neutral at JPMorgan.
Genzyme (GENZ) Raised to Buy at Citigroup.
HSBC Holdings plc (HBC) Raised to Buy at BofA Merrill Lynch; Started as Outperform at FBR.
Sinovac Biotech Ltd. (SVA) Reiterated Overweight at Piper Jaffray.
US BAncorp (USB) Raised to Outperform at Baird.
US Steel (X) Raised to Conviction Buy List at Goldman Sachs; replaces Freeport McMoRan (FCX).
You can join our open email distribution list to receive daily emails with analyst upgrades and downgrades, top day trader alerts, market rumors, merger activity, IPOs and secondary offerings, Warren Buffett and guru activity and more.
JON C. OGG
100 Million Americans Are Missing This Crucial Retirement Tool
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
